
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
Tianshu Xiao, Jianming Lü, Jun Zhang, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 2, pp. 202-209
Open Access | Times Cited: 127
Tianshu Xiao, Jianming Lü, Jun Zhang, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 2, pp. 202-209
Open Access | Times Cited: 127
Showing 1-25 of 127 citing articles:
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Structural impact on SARS-CoV-2 spike protein by D614G substitution
Jun Zhang, Yongfei Cai, Tianshu Xiao, et al.
Science (2021) Vol. 372, Iss. 6541, pp. 525-530
Open Access | Times Cited: 424
Jun Zhang, Yongfei Cai, Tianshu Xiao, et al.
Science (2021) Vol. 372, Iss. 6541, pp. 525-530
Open Access | Times Cited: 424
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Yongfei Cai, Jun Zhang, Tianshu Xiao, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 642-648
Open Access | Times Cited: 236
Yongfei Cai, Jun Zhang, Tianshu Xiao, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 642-648
Open Access | Times Cited: 236
Wuhan to World: The COVID-19 Pandemic
Ashok Kumar, Rita Gill Singh, Jaskaran Kaur, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 201
Ashok Kumar, Rita Gill Singh, Jaskaran Kaur, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 201
Structure of SARS-CoV-2 spike protein
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Current Opinion in Virology (2021) Vol. 50, pp. 173-182
Open Access | Times Cited: 190
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Current Opinion in Virology (2021) Vol. 50, pp. 173-182
Open Access | Times Cited: 190
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
Tzu‐Jing Yang, Pei‐Yu Yu, Yuan‐Chih Chang, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 9, pp. 731-739
Open Access | Times Cited: 156
Tzu‐Jing Yang, Pei‐Yu Yu, Yuan‐Chih Chang, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 9, pp. 731-739
Open Access | Times Cited: 156
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 148
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 148
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 138
Jun Zhang, Yongfei Cai, Christy L. Lavine, et al.
Cell Reports (2022) Vol. 39, Iss. 4, pp. 110729-110729
Open Access | Times Cited: 138
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122
The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes
Shawn M. Costello, Sophie R. Shoemaker, Helen T. Hobbs, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 3, pp. 229-238
Open Access | Times Cited: 120
Shawn M. Costello, Sophie R. Shoemaker, Helen T. Hobbs, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 3, pp. 229-238
Open Access | Times Cited: 120
Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
Canrong Wu, Wanchao Yin, Yi Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3021-3033
Open Access | Times Cited: 102
Canrong Wu, Wanchao Yin, Yi Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3021-3033
Open Access | Times Cited: 102
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, et al.
Science (2022) Vol. 375, Iss. 6578
Open Access | Times Cited: 75
Katherine Nabel Smith, Sarah A. Clark, Sundaresh Shankar, et al.
Science (2022) Vol. 375, Iss. 6578
Open Access | Times Cited: 75
Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
Wei Shi, Yongfei Cai, Haisun Zhu, et al.
Nature (2023) Vol. 619, Iss. 7969, pp. 403-409
Open Access | Times Cited: 54
Wei Shi, Yongfei Cai, Haisun Zhu, et al.
Nature (2023) Vol. 619, Iss. 7969, pp. 403-409
Open Access | Times Cited: 54
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
Lixiao Xing, Zhimin Liu, Xinling Wang, et al.
Cell (2025)
Closed Access | Times Cited: 1
Lixiao Xing, Zhimin Liu, Xinling Wang, et al.
Cell (2025)
Closed Access | Times Cited: 1
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
Carlos Cruz‐Teran, Karthik Tiruthani, Morgan D. McSweeney, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 100-117
Open Access | Times Cited: 79
Carlos Cruz‐Teran, Karthik Tiruthani, Morgan D. McSweeney, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 100-117
Open Access | Times Cited: 79
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
Alexander J. Pak, Alvin Yu, Zunlong Ke, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Alexander J. Pak, Alvin Yu, Zunlong Ke, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies
Shan Luo, Ying Liang, Tommy Hon Ting Wong, et al.
International Journal of Epidemiology (2022) Vol. 51, Iss. 4, pp. 1088-1105
Open Access | Times Cited: 42
Shan Luo, Ying Liang, Tommy Hon Ting Wong, et al.
International Journal of Epidemiology (2022) Vol. 51, Iss. 4, pp. 1088-1105
Open Access | Times Cited: 42
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, et al.
Cell Reports Physical Science (2023) Vol. 4, Iss. 4, pp. 101346-101346
Open Access | Times Cited: 35
Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, et al.
Cell Reports Physical Science (2023) Vol. 4, Iss. 4, pp. 101346-101346
Open Access | Times Cited: 35
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2
Ruili Huang, Miao Xu, Hu Zhu, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 6, pp. 747-753
Open Access | Times Cited: 45
Ruili Huang, Miao Xu, Hu Zhu, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 6, pp. 747-753
Open Access | Times Cited: 45
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
Philipp Jörrißen, Paula Schütz, Matthias Weiand, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Philipp Jörrißen, Paula Schütz, Matthias Weiand, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10836-10836
Open Access | Times Cited: 40
Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10836-10836
Open Access | Times Cited: 40